Susquehanna International Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,100
| Closed | -$248K | – | 14346 |
|
|
2021
Q3 | $248K | Sell |
9,100
-2,500
| -22% | -$61.8K | ﹤0.01% | 11032 |
|
|
2021
Q2 | $198K | Buy |
+11,600
| New | +$217K | ﹤0.01% | 11617 |
|
|
2020
Q2 | – | Sell |
-55,700
| Closed | -$660K | – | 11271 |
|
|
2020
Q1 | $660K | Buy |
55,700
+43,000
| +339% | +$953K | ﹤0.01% | 6335 |
|
|
2019
Q4 | $316K | Buy |
+12,700
| New | +$257K | ﹤0.01% | 7911 |
|
|
2019
Q3 | – | Sell |
-45,800
| Closed | -$1.04M | – | 11086 |
|
|
2019
Q2 | $1.04M | Buy |
45,800
+2,200
| +5% | +$59.3K | ﹤0.01% | 5553 |
|
|
2019
Q1 | $1.4M | Sell |
43,600
-300
| -0.7% | -$9.28K | ﹤0.01% | 4348 |
|
|
2018
Q4 | $1.24M | Sell |
43,900
-11,700
| -21% | -$343K | ﹤0.01% | 4296 |
|
|
2018
Q3 | $1.6M | Buy |
55,600
+39,400
| +243% | +$1.18M | ﹤0.01% | 4361 |
|
|
2018
Q2 | $607K | Buy |
16,200
+1,300
| +9% | +$51K | ﹤0.01% | 6405 |
|
|
2018
Q1 | $586K | Buy |
+14,900
| New | +$544K | ﹤0.01% | 6306 |
|
|
2017
Q4 | – | Sell |
-13,800
| Closed | -$430K | – | 10144 |
|
|
2017
Q3 | $430K | Buy |
13,800
+5,100
| +59% | +$151K | ﹤0.01% | 6772 |
|
|
2017
Q2 | $243K | Sell |
8,700
-18,200
| -68% | -$412K | ﹤0.01% | 7955 |
|
|
2017
Q1 | $461K | Buy |
+26,900
| New | +$377K | ﹤0.01% | 6632 |
|
Susquehanna International Group's XENT Position: Q2 2022 in Review
Susquehanna International Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 30,917 shares — an estimated $866K sold.
Susquehanna International Group first reported a position in XENT in Q4 2015 and held it in 16 quarters. The position peaked at $2.28M in Q2 2017. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Susquehanna International Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Susquehanna International Group sold 30,917 Intersect ENT, Inc shares in Q2 2022, an estimated $866K.
- Susquehanna International Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 16 quarters.
- Susquehanna International Group's Intersect ENT, Inc position peaked at $2.28M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.